Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renovaro Biosciences (RENB)
NASDAQ:RENB
| Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -121.86K | $ -113.50K | $ -123.59K | $ -391.42K | $ -366.27K |
| Operating Income | $ -81.64M | $ -38.56M | $ -116.08M | $ -23.40M | $ -11.92M |
| EBITDA | $ -79.52M | $ -19.48M | $ -22.70M | $ -23.28M | $ -11.51M |
| Net Income | $ -80.65M | $ -39.68M | $ -113.43M | $ -26.72M | $ -11.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 220.47K | $ 1.87M | $ 9.17M | $ 20.66M | $ 8.70M |
| Total Assets | $ 163.13M | $ 58.30M | $ 84.63M | $ 189.61M | $ 178.10M |
| Total Debt | $ 3.79M | $ 5.59M | $ 7.02M | $ 7.31M | $ 7.58M |
| Net Debt | $ 3.57M | $ 3.72M | $ -2.16M | $ -13.35M | $ -1.11M |
| Total Liabilities | $ 31.15M | $ 11.80M | $ 12.01M | $ 14.94M | $ 11.83M |
| Stockholders' Equity | $ 131.98M | $ 46.50M | $ 72.62M | $ 174.66M | $ 166.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.04M | $ -11.80M | $ -15.74M | $ -20.66M | $ -10.64M |
| Operating Cash Flow | $ -10.97M | $ -11.77M | $ -15.73M | $ -20.61M | $ -10.46M |
| Investing Cash Flow | $ -1.26M | $ -29.77K | $ -5.16K | $ -48.89K | $ -184.46K |
| Financing Cash Flow | $ 10.52M | $ 4.52M | $ 4.25M | $ 32.60M | $ 7.20M |
Renovaro Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.